Twist Bioscience Corp (TWST) operating KPIs
TWSTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 13/30345% above fair value
$152.78−20.67 (-11.92%)
Close on Oct 30, 2026Market cap $9.58BP/E –Yield –
KPIs
Operating metrics that drive Twist Bioscience's business
Coming soon
This tab will track the numbers specific to Twist Bioscience's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.